Integrated prediction and decision models are valuable in informing personalized decision making.

OBJECTIVES To show how prediction models can be incorporated into decision models, to allow for personalized decisions, and to assess the value of this approach using the management of the neck in early-stage oral cavity squamous cell carcinoma as an example. STUDY DESIGN AND SETTING In a decision model, three approaches were compared: a "population-based" approach in which patients undergo the strategy that is optimal for the population; a "perfectly predicted" approach, in which each patient receives the optimal strategy for that specific patient; and a "prediction model" approach in which each patient receives the strategy that is optimal based on prediction models. The average differences in costs and quality-adjusted life years (QALYs) for the population between these approaches were studied. RESULTS The population-based approach resulted on average in 4.9158 QALYs with €8,675 in costs, per patient. The perfectly predicted approach yielded 0.21 more QALYs and saved €1,024 per patient. The prediction model approach yielded 0.0014 more QALYs and saved €152 per patient compared with the population-based approach. CONCLUSION The perfectly predicted approach shows that personalized care is worthwhile. However, current prediction models in the field of oral cavity squamous cell carcinoma have limited value. Incorporating prediction models into decision models appears to be a valuable method to assess the value of personalized decision making.

[1]  Mark Sculpher,et al.  Subgroups and Heterogeneity in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[2]  M. Merkx,et al.  Quality of life after different procedures for regional control in oral cancer patients: cross‐sectional survey , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[3]  J. Johansen,et al.  The prognostic significance of histological features in oral squamous cell carcinoma. , 2009, Journal of Oral Pathology & Medicine.

[4]  J. Woolgar Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. , 1999, The British journal of oral & maxillofacial surgery.

[5]  P. Dijkstra,et al.  Impact of shoulder complaints after neck dissection on shoulder disability and quality of life , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  E. Steyerberg,et al.  Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.

[7]  Andrea Ganna,et al.  Prediction impact curve is a new measure integrating intervention effects in the evaluation of risk models. , 2016, Journal of clinical epidemiology.

[8]  Richard D Riley,et al.  Prognosis research strategy (PROGRESS) 4: Stratified medicine research , 2013, BMJ : British Medical Journal.

[9]  P. Royston,et al.  Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.

[10]  Jonathan R. Clark,et al.  Improved survival with elective neck dissection in thick early‐stage oral squamous cell carcinoma , 2012, Head & neck.

[11]  Jonathan Karnon,et al.  Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern , 2022 .

[12]  M. Palta,et al.  US Norms for Six Generic Health-Related Quality-of-Life Indexes From the National Health Measurement Study , 2007, Medical care.

[13]  Trudy van der Weijden,et al.  Clinical practice guidelines and patient decision aids. An inevitable relationship. , 2012, Journal of clinical epidemiology.

[14]  E. Steyerberg,et al.  Prognosis: A variable parameter. Dynamic prognostic modeling in head and neck squamous cell carcinoma , 2012, Head & neck.

[15]  K. Moons,et al.  Diagnostic and prognostic prediction models , 2013, Journal of thrombosis and haemostasis : JTH.

[16]  G. Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement , 2015, Annals of Internal Medicine.

[17]  Janneke Grutters,et al.  The role of the expected value of individualized care in cost-effectiveness analyses and decision making. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[18]  S. Stoeckli,et al.  Evaluation of Clinical and Histomorphological Parameters as Potential Predictors of Occult Metastases in Sentinel Lymph Nodes of Early Squamous Cell Carcinoma of the Oral Cavity , 2010, Annals of Surgical Oncology.

[19]  M. Rovers,et al.  Management of the N0 neck in early stage oral squamous cell cancer: a modeling study of the cost-effectiveness. , 2013, Oral oncology.

[20]  M C Weinstein,et al.  Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  Anirban Basu,et al.  Value of Information on Preference Heterogeneity and Individualized Care , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  S le Cessie,et al.  Prediction of survival in patients with head and neck cancer , 2001, Head & neck.

[23]  A Basu,et al.  A Framework for Prioritizing Research Investments in Precision Medicine. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  Jonathan R. Clark,et al.  Established prognostic variables in NO oral carcinoma , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  E. Balas,et al.  Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success , 2005, BMJ : British Medical Journal.

[26]  L. Fleck Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices. , 2012, New biotechnology.

[27]  James E. Stahl,et al.  Acknowledging Patient Heterogeneity in Economic Evaluation , 2013, PharmacoEconomics.

[28]  Carlos Gamallo,et al.  Elective neck dissection in early‐stage oral squamous cell carcinoma—does it influence recurrence and survival? , 2007, Head & neck.

[29]  A. van der Bilt,et al.  Neck and shoulder function in patients treated for oral malignancies: A 1‐year prospective cohort study , 2013, Head & neck.

[30]  Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity , 1997 .

[31]  D. Soutar,et al.  Improved Staging of Cervical Metastases in Clinically Node-Negative Patients With Head and Neck Squamous Cell Carcinoma , 2004, Annals of Surgical Oncology.

[32]  Martin J Buxton,et al.  Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. , 2003, Health economics.

[33]  K. Yoneda,et al.  Risk Factors of Metastasis in Oral Squamous Cell Carcinomas , 2000, Oncology.

[34]  J. Piccirillo,et al.  Update and external validation of a head and neck cancer prognostic model , 2013, Head & neck.